Trials / Completed
CompletedNCT00385320
Evaluate Protective Efficacy of Diff Strengths of Human Rotavirus Vaccine After Admn of 2 Doses to Infants Aged 2 Months
To Assess the Efficacy, Immuno & Safety of 2 Doses of GSK HRV Vaccine at Different Virus Concentrations in Healthy Infants Aged 2 Months & Previously Uninfected With HRV, Concurrently Given With DTPw-HBV, Hib.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 2,640 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 6 Weeks – 12 Weeks
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to test how infants respond to different strengths of the human rotavirus vaccine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | HRV vaccine |
Timeline
- Start date
- 2001-05-31
- Primary completion
- 2003-04-30
- Completion
- 2003-04-30
- First posted
- 2006-10-09
- Last updated
- 2019-12-27
Source: ClinicalTrials.gov record NCT00385320. Inclusion in this directory is not an endorsement.